EW vs SENS · P/E 47, rev $3.39B vs rev $26.2M
Edwards Lifesciences Corp (EW) versus Senseonics Holdings, Inc. Common Stock (SENS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Senseonics Holdings, Inc. Common Stock (SENS) is a medical devices company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SENS revenue for 2026-06-30 was $26.2M. Net income was -$69.0M. SENS currently screens at market cap $377.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SENS currently screens at market cap $377.4M.
Not investment advice. Open the EW and SENS stock pages for the full models.
Not investment advice.